Novo Nordisk reported DKK26.89B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Bausch Health Companies USD -1.42B 1.31B Mar/2026
Bristol-Myers Squibb USD 2.68B 1.59B Mar/2026
Eli Lilly USD 7.4B 760M Mar/2026
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
Merck USD -4.24B 7.2B Mar/2026
Novartis USD 3.16B 747M Mar/2026
Novo Nordisk DKK 26.89B 388M Dec/2025
Novo Nordisk DKK 4.03B 25.01B Jun/2025
Pacira USD 2.92M 1.28M Mar/2026
Sanofi EUR 1.61B 2.42B Mar/2026
Supernus Pharmaceuticals USD -2.29M 1.81M Mar/2026